Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen-Jing Yang

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Cell Reports. Medicine|May 1, 2025
Integrative proteomic profiling of tumor and plasma extracellular vesicles identifies a diagnostic biomarker panel for colorectal cancerJun Wang, Chen-Zheng Gu, Peng-Xiang Wang, et al.
Cell Death & Disease|October 23, 2020
BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activityWen-Jing Yang, Yun-Fan Sun, An-Li Jin, et al.
Journal of Hematology & Oncology|April 12, 2019
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosisXiao-Lu Ma, Min-Na Shen, Bo Hu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 26, 2020
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolizationXiao-Lu Ma, Xu-Dong Qu, Wen-Jing Yang, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Cell Reports. Medicine|May 1, 2025
Integrative proteomic profiling of tumor and plasma extracellular vesicles identifies a diagnostic biomarker panel for colorectal cancerJun Wang, Chen-Zheng Gu, Peng-Xiang Wang, et al.
Cell Death & Disease|October 23, 2020
BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activityWen-Jing Yang, Yun-Fan Sun, An-Li Jin, et al.
Journal of Hematology & Oncology|April 12, 2019
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosisXiao-Lu Ma, Min-Na Shen, Bo Hu, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 26, 2020
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolizationXiao-Lu Ma, Xu-Dong Qu, Wen-Jing Yang, et al.
Pageof 9